Ascendis Pharma A (ASND) Investment Gain (Loss) (2020 - 2024)
Ascendis Pharma A (ASND) posted Investment Gain (Loss) of -$1068.6 for Q4 2024, down 100.01% sequentially from $8.0 million in Q1 2024, and down 100.02% YoY from $7.1 million in Q1 2024.
Ascendis Pharma A (ASND) Investment Gain (Loss) (2020 - 2024) Analysis & Trends
Ascendis Pharma A has reported Investment Gain (Loss) for 5 years, with the latest figure at -$1068.6 in Q4 2024.
- Quarterly Investment Gain (Loss) fell 100.02% year-over-year to -$1068.6 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$1068.6 (down 100.01% YoY) and the FY2024 annual result came in at $7.9 million, down 97.49% from the prior year.
- Investment Gain (Loss) eased to -$1068.6 in Q4 2024 per ASND's latest filing, from $8.0 million in the prior quarter.
- Over five years, Investment Gain (Loss) peaked at $227.3 million in Q1 2023 and troughed at -$1068.6 in Q4 2024.
- A 5-year average of $63.2 million and a median of $51.6 million in 2023 frame the typical range for Investment Gain (Loss).
- The sharpest annual moves came in 2023 and 2024: Investment Gain (Loss) jumped 212.11% in 2023, then plunged 100.02% in 2024.
- Over 5 years, Investment Gain (Loss) stood at $155.5 million in 2020, then slumped by 76.92% to $35.9 million in 2021, then surged by 59.18% to $57.1 million in 2022, then sank by 87.6% to $7.1 million in 2023, then plunged by 100.02% to -$1068.6 in 2024.
- According to Business Quant data, Investment Gain (Loss) over the past three periods registered -$1068.6, $8.0 million, and $7.1 million for Q4 2024, Q1 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investment Gain (Loss) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ascendis Pharma A | 15.40 Bn | 14.73 Bn | 268.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,068.60 |
| Mar 31, 2024 | 7.99 Mn |
| Dec 31, 2023 | 7.08 Mn |
| Sep 30, 2023 | 25.20 Mn |
| Jun 30, 2023 | 51.62 Mn |
| Mar 31, 2023 | 227.26 Mn |
| Dec 31, 2022 | 57.12 Mn |
| Sep 30, 2022 | 89.13 Mn |
| Jun 30, 2022 | 76.04 Mn |
| Mar 31, 2022 | 72.81 Mn |
| Dec 31, 2021 | 35.88 Mn |
| Sep 30, 2021 | 50.61 Mn |
| Jun 30, 2021 | 62.06 Mn |
| Mar 31, 2021 | 29.03 Mn |
| Dec 31, 2020 | 155.48 Mn |